Significant Ownership of Third Rock Ventures V, L.P.

Large-stake snapshot 1 signal
Large-stake filing summary
  • Recent SEC Schedule 13D/G filings for Third Rock Ventures V, L.P. focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager location
Boston, MA
Manager signature
/s/ Kevin Gillis - Kevin Gillis, Chief O.O of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.

Follow Filing Activity

Follow Third Rock Ventures V, L.P. and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Significant Ownership of Third Rock Ventures V, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RAPP Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share 20% $81,198,952 7,135,233 Third Rock Ventures V, L.P. 31 Dec 2024
SEPN Septerna, Inc. Common Stock, $0.001 par value per share 14% $43,509,137 6,215,591 0% Third Rock Ventures V, L.P. 31 Mar 2025

Schedules 13D/G Reported by Third Rock Ventures V, L.P.:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .